How should allergists deal with local reactions to allergen immunotherapy?

Current Allergy and Asthma Reports

Volumn 11, Issue 2, 2011, Pages 115-121

  Tankersley, Michael S ^a  

^a WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

Dose adjustments; Immunotherapy; Local reactions; Systemic reactions

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; CORTICOSTEROID;

ALLERGENICITY; CLINICAL PROTOCOL; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOCTOR PATIENT RELATION; EVIDENCE BASED MEDICINE; HUMAN; IMMUNOLOGICAL MONITORING; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; INJECTION SITE REACTION; INJECTION SITE SWELLING; OUTCOME ASSESSMENT; PATIENT EDUCATION; PREDICTIVE VALUE; REVIEW; SENSITIVITY AND SPECIFICITY; SUBCUTANEOUS IMMUNOTHERAPY; THERAPY EFFECT; TREATMENT PLANNING;

DESENSITIZATION, IMMUNOLOGIC; EDUCATION, MEDICAL, CONTINUING; HUMANS; HYPERSENSITIVITY; SKIN;

EID: 79955913038     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-010-0172-5     Document Type: Review

References (39)

1. Patterson R, Lieberman P, Irons JS, et al.: Immunotherapy. In: Middleton E Jr, Reed CE, Ellis EF (eds) Allergy: principles and practice. St Louis: The CV Mosby Company 1983, 1119-42.
2. Ramirez DA, Londono S, Evans R III: Adverse reactions to venom immunotherapy. Ann Allergy 1981, 47:435-9. (Pubitemid 12203224)
3. Practice parameters for allergen immunotherapy. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. J Allergy Clin Immunol 1996, 98:1001-11.
4. Prigal SJ. A 10-year study of repository injections of allergens: local reactions and their management. Ann Allergy 1972;30: 529-35.
5. Mauriello PM, Barde SH, Georgitis JW, Reisman RE. Natural history of large local reactions from stinging insects. J Allergy Clin Immunol 1984;74:494-8. (Pubitemid 15203411)
6. Nelson BL, Dupont LA, Reid MJ. Prospective survey of local and systemic reactions to immunotherapy with pollen extracts. Ann Allergy 1986;56:331-4. (Pubitemid 16102118)
7. Hepner MJ, Ownby DR, et al. The safety of immunotherapy - a prospective study [abstract]. J Allergy Clin Immunol 1987;79:133.
8. Ohman JL Jr. Allergen immunotherapy: review of efficacy and current practice. Med Clin N Amer 1992;76:977-91.
9. Van Metre TE Jr, Adkinson NF (1993) Immunotherapy for aeroallergen disease. In: Middleton E Jr, Reed CE, Ellis EF, et al. (eds) Allergy: principles and practice. St Louis: Mosby, 1489-509
10. Schoenwetter WF. Safe allergen immunotherapy: the correct allergen, the appropriate patient, the adequate dose. Postgrad Med 1996;100:123-6,131-5.
11. Craig T, Sawyer AM, Fornadley JA. Use of immunotherapy in a primary care office. Am Fam Physician 1998;57:1888-94. (Pubitemid 28183630)
12. WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998;44:1-42.
13. Theodoropoulos DS, Lockey RF. Allergen immunotherapy: guidelines, update, and recommendations of the World Health Organization. Allergy and Asthma Proc 2000;21:159-66.
14. Nelson HS (1998) Immunotherapy for inhalant allergens. In: Middleton E Jr, Reed CE, Ellis EF, et al. (eds) Allergy: Principles and Practice. St Louis: Mosby, 1050-62.
15. Rhodes BJ. Patient dropouts before completion of optimal dose, multiple allergen immunotherapy. Ann Allergy Asthma Immunol 1999;82:281-6. (Pubitemid 29141089)
16. Tankersley MS, Butler KK, Butler WK and Goetz DW. Local reactions during allergen immunotherapy do not require dose adjustment. J Allergy Clin Immunol 2000;106:840-3.
17. Grammer LC (2002) Principles of immunologic management of allergic diseases due to extrinsic antigens. In: Grammer LC, Greenberger PA (eds) Patterson's Allergic Diseases. Philadelphia: Lippincott Williams and Wilkins, pp 183-94.
18. Matsui EC, Eggleston PA(2003) Immunotherapy for allergic disease. In: Leung DYM, Sampson HA, Geha RS, Szefler SJ (eds) Pediatric Allergy: Principles and Practice. St Louis: Mosby, pp 277-85.
19. Allergen Immunotherapy: A Practice Parameter. Ann Allergy 2003; 90:S1-40.
20. Tankersley MS. Local reactions during allergen immunotherapy do not require dose adjustment: data over 3 years from a solo practice [abstract]. Ann Allergy Asthma Immunol 2003;90:100 (14).
21. Kelso JM. The rate of systemic reactions to immunotherapy injections is the same whether or not the dose is reduced after a local reaction. Ann Allergy Asthma Immunol. 2004;92:225-7. (Pubitemid 38233660)
22. Tankersley MS. Dose adjustments are unnecessary for local reactions occurring at immunotherapy satellite clinics. J Allergy Clin Immunol 2004;113:S111.
23. Roy SR, Sigmon JR, Olivier J, Moffitt JE, et al. Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy. Ann Allergy Asthma Immunol 2007;99:82-6. (Pubitemid 47075956)
24. Allergen Immunotherapy: A Practice Parameter Second Update. J Allergy Clin Immunol 2007;120:S25-85.
25. Calabria CW, Stolfe A, Tankersley MS. The REPEAT study: recognizing and evaluating periodic local reactions in allergen immunotherapy and associated systemic reactions. Ann Allergy Asthma Immunol 2010, In press. This study is a follow-up to a previous study from another center that found an association of systemic reactions in patients who experienced repeated LRs. However, this study was performed in a clinic that did not dose adjust for LRs.
26. Coop CA and Tankersley MS. Dose adjustment practices among allergists for local reactions to IT. Ann Allergy Asthma Immunol 2007, 99:77-81. (Pubitemid 47075955)
27. More DR, Hagan LL. Factors affecting compliance with allergen immunotherapy at a military medical center. Ann Allergy Asthma Immunol 2002;88:391-4. (Pubitemid 34408565)
28. Coop CA and Tankersley MS. Patient perceptions regarding local reactions from allergen immunotherapy injections. Ann Allergy Asthma Immunol 2008, 101:96-100. This was the first survey to evaluate patient perceptions about their own LRs. There was a 100% contact rate with all the patients in this clinic, which did not practice dose adjustments for LRs.
29. Calabria CW, Coop CA, Tankersley MS. The LOCAL study: local reactions do not predict local reactions to immunotherapy. J Allergy Clin Immunol 2009, 124:739-44. After it had been established that LRs did not predict systemic reactions, this study examined whether LRs predicted further LRs (they do not). The conclusions shape the practice of those who dose adjust out of concern for further LRs.
30. Calabria CW, Coop CA, Tankersley MS. The GILL study: glycerin-induced local reactions to immunotherapy. J Allergy Clin Immunol 2008;121:222-6. This study examined glycerin and allergen content and any association with LRs.
31. World Allergy Organization: Allergen immunotherapy: a synopsis. Available at http://www.worldallergy.org/professional/allergic- diseases-center/ immunotherapy/immunotherapysynopsis.php. Accessed October 2010.
32. Berchtold E, Maibach R, Muller U. Reduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadine. Clin Exp Allergy 1992;22:59-65.
33. Brockow K, Kiehn M, Riethmuller C, et al. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1997;100:458-63.
34. Reimers A, Hari Y, Muller U. Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial. Allergy 2000;55:484-8. (Pubitemid 30230359)
35. Nielsen L, Johnsen CR, Mosbech H, et al. Antihistamine premedication in specific cluster immunotherapy: a double-blind, placebo-controlled study. J Allergy Clin Immunol 1996;97:1207-13.
36. Portnoy J, Bagstad K, Kanarek H, et al. Premedication reduces the incidence of systemic reactions during inhalant rush immunotherapy with mixtures of allergenic extracts. Ann Allergy 1994;73:409-18. (Pubitemid 24368195)
37. Roberts G, Hurley C, Turcanu V, Lack G. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma. J Allergy Clin Immunol 2006;117:263-8. (Pubitemid 43190138)
38. Wohrl S, Gamper S, Hemmer W, et al. Premedication with montelukast reduces local reactions of allergen immunotherapy. Int Arch Allergy Immunol 2007;144:137-42. (Pubitemid 47414328)
39. Metzger WJ, Turner E, Patterson R. The safety of immunotherapy during pregnancy. J Allergy Clin Immunol 1978;61:268-72. (Pubitemid 8329513)